This trial will also compare the accuracy of liquid biopsies (blood tests) to standard bone marrow biopsies in detecting MRD.
- Multiple Myeloma
3 Primary · 2 Secondary · Reporting Duration: 3 years
Awards & Highlights
1 Treatment Group
1 of 1
56 Total Participants · 1 Treatment Group
Primary Treatment: Screening Phase · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there still openings for participants in this clinical research?
"Affirmative. According to the information on clinicaltrials.gov, this trial is currently recruiting patients who it first posted about in October of 2019 and updated most recently around January 8th 2021. 56 participants are needed from 1 study site." - Anonymous Online Contributor
What is the maximum enrollment capacity for this clinical trial?
"Affirmative. Clinicaltrials.gov data states that this trial, which was launched on October 30th 2019, is actively enlisting people into the research project. The clinical study requires 56 participants from one medical facility to be recruited." - Anonymous Online Contributor